u0430u0434u0430u043fu0442u043eu0433u0435u043du043du044bu0439 officinalis drug for oral use

摘要

the invention relates to medicine, specifically to the medicines for oral use, which is an adaptogen effectsand can be used for the recovery of the body after sustained disease in intensive physical loadas well as to enhance efficiency and facilitate the adaptation of the organism to the extreme conditions of the external environment.the invention is a pharmaceutical preparation for oral use u0430u0434u0430u043fu0442u043eu0433u0435u043du043du043eu0433u043e a highly curative effectiveness in the dmv u0443u0442u0441u0442u0432u0438u0438 side effects.the challenge is, however, that the drug itself for oral use, containing a biologically active substance - amber acid substances with u0432u0438u0442u0430u043cu0438u043du043du044bu043c actand the auxiliary substance, is different in that it additionally contains a biologically active substance u0440u0438u0431u043eu043au0441u0438u043d, as substances with wheat u0430u043cu0438u043du043du044bu043c actu0440u0438u0431u043eu0444u043bu0430u0432u0438u043du0430 u043cu043eu043du043eu043du0443u043au043bu0435u0430u0442u0438u0434 sodium and nicotinamide, as well as auxiliary substances - targeted supplements and u043au0438u0448u0435u0447u043du043e - u0440u0430u0441u0442u0432u043eu0440u0438u043cu043eu0435 coating of the copolymer u043cu0435u0442u0438u043bu0430u043au0440u0438u043bu043eu0432 oh, acid and u044du0442u0438u043bu0430u043au0440u0438u043bu0430u0442u0430,next the ratio of components, the iau.%.